Raymond James Financial’s Checkpoint Therapeutics CKPT Stock Holding History

Raymond James Financial’s Portfolio CKPT Stock Details CKPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-25,220	Closed	-$102K	–	7009
2025 Q1	$102K	Buy	25,220 +4,225	+20%	+$14.1K	﹤0.01%	4545
2024 Q4	$67.2K	Buy	+20,995	New	+$71.2K	﹤0.01%	4573

Raymond James Financial's CKPT Position: Q2 2025 in Review

Raymond James Financial sold out of Checkpoint Therapeutics (CKPT) in Q2 2025, closing a stake of 25,220 shares — an estimated $102K sold.

Raymond James Financial first reported a position in CKPT in Q4 2024 and held it in 2 quarters. The position peaked at $102K in Q1 2025. 0 funds tracked by Wall St. Rank hold CKPT as of Q2 2025.

Raymond James Financial reported no remaining Checkpoint Therapeutics position as of Q2 2025 after selling out during the quarter.
Raymond James Financial sold 25,220 Checkpoint Therapeutics shares in Q2 2025, an estimated $102K.
Raymond James Financial first reported a position in Checkpoint Therapeutics in Q4 2024 and held it in 2 quarters.
Raymond James Financial's Checkpoint Therapeutics position peaked at $102K in Q1 2025.
0 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q2 2025.

Based on Raymond James Financial's 13F filing for Q2 2025, filed 14 Aug 2025.